Cargando…
The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review
BACKGROUND: Osteogenesis imperfecta (OI) is a rare heritable connective tissue disorder primarily characterised by skeletal deformity and fragility, and an array of secondary features. The purpose of this review was to capture and quantify the published evidence relating specifically to the clinical...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945474/ https://www.ncbi.nlm.nih.gov/pubmed/36814274 http://dx.doi.org/10.1186/s13023-023-02627-3 |
_version_ | 1784892149112766464 |
---|---|
author | Rapoport, Maria Bober, Michael B. Raggio, Cathleen Wekre, Lena Lande Rauch, Frank Westerheim, Ingunn Hart, Tracy van Welzenis, Taco Mistry, Arun Clancy, James Booth, Lucy Prince, Samantha Semler, Oliver |
author_facet | Rapoport, Maria Bober, Michael B. Raggio, Cathleen Wekre, Lena Lande Rauch, Frank Westerheim, Ingunn Hart, Tracy van Welzenis, Taco Mistry, Arun Clancy, James Booth, Lucy Prince, Samantha Semler, Oliver |
author_sort | Rapoport, Maria |
collection | PubMed |
description | BACKGROUND: Osteogenesis imperfecta (OI) is a rare heritable connective tissue disorder primarily characterised by skeletal deformity and fragility, and an array of secondary features. The purpose of this review was to capture and quantify the published evidence relating specifically to the clinical, humanistic, and economic impact of OI on individuals, their families, and wider society. METHODS: A systematic scoping review of 11 databases (MEDLINE, MEDLINE in-progress, EMBASE, CENTRAL, PsycINFO, NHS EED, CEA Registry, PEDE, ScHARRHUd, Orphanet and Google Scholar), supplemented by hand searches of grey literature, was conducted to identify OI literature published 1st January 1995–18th December 2021. Searches were restricted to English language but without geographical limitations. The quality of included records was assessed using the AGREE II checklist and an adapted version of the JBI cross-sectional study checklist. RESULTS: Of the identified 7,850 records, 271 records of 245 unique studies met the inclusion criteria; overall, 168 included records examined clinical aspects of OI, 67 provided humanistic data, 6 reported on the economic impact of OI, and 30 provided data on mixed outcomes. Bone conditions, anthropometric measurements, oral conditions, diagnostic techniques, use of pharmacotherapy, and physical functioning of adults and children with OI were well described. However, few records included current care practice, diagnosis and monitoring, interactions with the healthcare system, or transition of care across life stages. Limited data on wider health concerns beyond bone health, how these concerns may impact health-related quality of life, in particular that of adult men and other family members, were identified. Few records described fatigue in children or adults. Markedly few records provided data on the socioeconomic impact of OI on patients and their caregivers, and associated costs to healthcare systems, and wider society. Most included records had qualitative limitations. CONCLUSION: Despite the rarity of OI, the volume of recently published literature highlights the breadth of interest in the OI field from the research community. However, significant data gaps describing the experience of OI for individuals, their families, and wider society warrant further research to capture and quantify the full impact of OI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02627-3. |
format | Online Article Text |
id | pubmed-9945474 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-99454742023-02-23 The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review Rapoport, Maria Bober, Michael B. Raggio, Cathleen Wekre, Lena Lande Rauch, Frank Westerheim, Ingunn Hart, Tracy van Welzenis, Taco Mistry, Arun Clancy, James Booth, Lucy Prince, Samantha Semler, Oliver Orphanet J Rare Dis Review BACKGROUND: Osteogenesis imperfecta (OI) is a rare heritable connective tissue disorder primarily characterised by skeletal deformity and fragility, and an array of secondary features. The purpose of this review was to capture and quantify the published evidence relating specifically to the clinical, humanistic, and economic impact of OI on individuals, their families, and wider society. METHODS: A systematic scoping review of 11 databases (MEDLINE, MEDLINE in-progress, EMBASE, CENTRAL, PsycINFO, NHS EED, CEA Registry, PEDE, ScHARRHUd, Orphanet and Google Scholar), supplemented by hand searches of grey literature, was conducted to identify OI literature published 1st January 1995–18th December 2021. Searches were restricted to English language but without geographical limitations. The quality of included records was assessed using the AGREE II checklist and an adapted version of the JBI cross-sectional study checklist. RESULTS: Of the identified 7,850 records, 271 records of 245 unique studies met the inclusion criteria; overall, 168 included records examined clinical aspects of OI, 67 provided humanistic data, 6 reported on the economic impact of OI, and 30 provided data on mixed outcomes. Bone conditions, anthropometric measurements, oral conditions, diagnostic techniques, use of pharmacotherapy, and physical functioning of adults and children with OI were well described. However, few records included current care practice, diagnosis and monitoring, interactions with the healthcare system, or transition of care across life stages. Limited data on wider health concerns beyond bone health, how these concerns may impact health-related quality of life, in particular that of adult men and other family members, were identified. Few records described fatigue in children or adults. Markedly few records provided data on the socioeconomic impact of OI on patients and their caregivers, and associated costs to healthcare systems, and wider society. Most included records had qualitative limitations. CONCLUSION: Despite the rarity of OI, the volume of recently published literature highlights the breadth of interest in the OI field from the research community. However, significant data gaps describing the experience of OI for individuals, their families, and wider society warrant further research to capture and quantify the full impact of OI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02627-3. BioMed Central 2023-02-22 /pmc/articles/PMC9945474/ /pubmed/36814274 http://dx.doi.org/10.1186/s13023-023-02627-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Rapoport, Maria Bober, Michael B. Raggio, Cathleen Wekre, Lena Lande Rauch, Frank Westerheim, Ingunn Hart, Tracy van Welzenis, Taco Mistry, Arun Clancy, James Booth, Lucy Prince, Samantha Semler, Oliver The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review |
title | The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review |
title_full | The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review |
title_fullStr | The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review |
title_full_unstemmed | The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review |
title_short | The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review |
title_sort | patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945474/ https://www.ncbi.nlm.nih.gov/pubmed/36814274 http://dx.doi.org/10.1186/s13023-023-02627-3 |
work_keys_str_mv | AT rapoportmaria thepatientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT bobermichaelb thepatientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT raggiocathleen thepatientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT wekrelenalande thepatientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT rauchfrank thepatientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT westerheimingunn thepatientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT harttracy thepatientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT vanwelzenistaco thepatientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT mistryarun thepatientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT clancyjames thepatientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT boothlucy thepatientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT princesamantha thepatientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT semleroliver thepatientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT rapoportmaria patientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT bobermichaelb patientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT raggiocathleen patientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT wekrelenalande patientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT rauchfrank patientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT westerheimingunn patientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT harttracy patientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT vanwelzenistaco patientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT mistryarun patientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT clancyjames patientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT boothlucy patientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT princesamantha patientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview AT semleroliver patientclinicaljourneyandsocioeconomicimpactofosteogenesisimperfectaasystematicscopingreview |